科代診斷
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About 科代診斷
Co-Diagnostics, Inc. 是一家分子診斷公司，在美國和國際上開發、製造和銷售用於診斷測試的試劑，這些試劑通過核酸分子的檢測和/或分析發揮作用。它為 COVID-19、結核病、乙型和丙型肝炎、人乳頭瘤病毒、瘧疾、基孔肯雅熱、登革熱和寨卡病毒提供聚合酶鏈反應 (PCR) 診斷測試；對蚊子進行三項多重測試以鑑定蚊子所攜帶的疾病；和用於檢測傳染病的分子工具、用於癌症篩查的液體活檢和農業應用。該公司還提供鑑定植物和動物基因組遺傳特徵的測試；和便攜式 PCR 設備，設計用於在護理點和家庭環境中為患者提供 PCR。此外，它還打算將其他製造商的診斷設備作為獨立的實驗室系統出售。該公司成立於 2013 年，總部位於猶他州鹽湖城。
如何購買 科代診斷 (CODX)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 CODX
透過 RockFlow App 或網頁端搜尋 CODX，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.